Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eosinophilic esophagitis: from pathophysiology to management.
Ghisa M, Laserra G, Maniero D, Marabotto E, Barberio B, Pelizzaro F, Barbuscio I, Zingone F, Savarino V, Savarino E. Ghisa M, et al. Among authors: marabotto e. Minerva Gastroenterol (Torino). 2022 Mar;68(1):40-48. doi: 10.23736/S2724-5985.20.02780-4. Epub 2020 Dec 3. Minerva Gastroenterol (Torino). 2022. PMID: 33267562 Review.
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V. Savarino E, et al. Among authors: marabotto e. Am J Gastroenterol. 2010 May;105(5):1053-61. doi: 10.1038/ajg.2009.670. Epub 2009 Dec 8. Am J Gastroenterol. 2010. PMID: 19997095
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V, Malesci A, Tutuian R, Savarino V. Savarino E, et al. Among authors: marabotto e. Aliment Pharmacol Ther. 2011 Aug;34(4):476-86. doi: 10.1111/j.1365-2036.2011.04742.x. Epub 2011 Jun 14. Aliment Pharmacol Ther. 2011. PMID: 21671968 Free article.
Overweight is a risk factor for both erosive and non-erosive reflux disease.
Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V. Savarino E, et al. Among authors: marabotto e. Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22. Dig Liver Dis. 2011. PMID: 21944835
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V. Savarino E, et al. Among authors: marabotto e. Am J Gastroenterol. 2013 Nov;108(11):1731-42. doi: 10.1038/ajg.2013.287. Epub 2013 Sep 10. Am J Gastroenterol. 2013. PMID: 24019080 Clinical Trial.
115 results